Bill H.R.7790 titled “Infant Formula Supplemental Appropriations Act, 2022” was referred to the Committee on Appropriations and in addition to the Committee on the Budget for a period to be subsequently determined by the Speaker in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned by the House of Representatives. The bill is sponsored by Rep. Rosa DeLauro. Infant Formula Supplemental Appropriations Act, 2022This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States. Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U. S. market.
Most bills have a hearing where those involved explain why they are for or against the bill. Roughly 8,000 bills are addressed by committees each year but only about 800 make it to the floor of Congress, according to ushistory.org.
A 2019 report from the Brookings Institute argued committees aren’t capable of delving fully into the issues they address and are forced to rely on lobbyists.
| Bill Name | Sponsor | Action |
|---|---|---|
| Infant Formula Supplemental Appropriations Act, 2022 | Rep. DeLauro, Rosa L. | House of Representatives |
